Penicillin kills bacteria by sabotaging the construction of their cell walls, the rigid outer shell that keeps a bacterial cell from bursting under its own internal pressure. It does this by binding to the enzymes responsible for stitching the wall together, leaving structural weak points that eventually rupture. But the full story of what penicillin does to a bacterial cell is more layered than a simple “wall breaks, cell pops” narrative, involving molecular mimicry, self-destructive bacterial enzymes, and forms of survival that challenge the assumption that losing a cell wall is always fatal.
How Penicillin Mimics the Cell Wall’s Own Building Blocks
The bacterial cell wall is built from a mesh-like material called peptidoglycan, a lattice of sugar chains cross-linked by short chains of amino acids. The cross-linking step is critical: without it, the sugar strands would just hang loose, offering no structural support. The enzymes that perform this cross-linking are called penicillin-binding proteins, or PBPs, and they are penicillin’s primary targets.
Penicillin works because it happens to look, at a molecular level, like the piece of the bacterial building material that PBPs normally grab onto. Specifically, the part of the peptidoglycan precursor that PBPs recognize is a two-amino-acid tail. Penicillin’s core ring structure is similar enough to that tail to fool the enzyme into binding it. Once penicillin locks into the PBP’s active site, it forms a permanent chemical bond with a key part of the enzyme, jamming it in a locked position. The enzyme can no longer let go and move on to cross-link the next strand.1FEMS Microbiology Reviews. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis This is not a brief blockade; the bond is covalent, meaning the PBP is essentially disabled for good.
Different bacteria carry different sets of PBPs, sometimes a dozen or more, and each handles a slightly different construction task. Some elongate the cell, some build the wall at the division site where one cell splits into two, and others perform maintenance repairs. Penicillin can hit several of these at once, which is part of why it is so destructive: it does not just slow down wall construction in one spot but disrupts multiple building processes simultaneously.
From Binding to Bursting
Disabling PBPs stops new cross-links from forming, but the existing wall does not simply crumble on its own. Bacteria constantly remodel their walls, breaking old bonds to insert new material as the cell grows and divides. The enzymes that break those old bonds, called autolysins, keep working even after penicillin has shut down the enzymes that form new ones. The result is a wall that is being taken apart without being rebuilt. Weak spots accumulate until the internal pressure of the cell, which can be substantial, pushes through the compromised wall and the cell bursts.
Research on Staphylococcus aureus has shown that autolysins become deregulated at the exact sites where new cross-wall formation has been disrupted by penicillin. Small defects appear in the wall at these localized points, and those defects eventually cascade into full-scale lysis, the complete dissolution of the cell.2PubMed Central. Localized perforation of the cell wall by a major autolysin: atl gene products and the onset of penicillin-induced lysis of Staphylococcus aureus This means the lethal blow is partly self-inflicted: penicillin sets the stage, but the bacterium’s own wall-recycling machinery delivers the final strike.
The picture is even more complicated than wall rupture alone. A 2023 study found that the loss of wall integrity triggers a cascade of downstream events inside the cell, including metabolic disruptions and oxidative damage, which contribute to killing.3PubMed Central. On the mechanisms of lysis triggered by perturbations of bacterial cell wall biosynthesis In other words, penicillin does not merely poke a hole; it sets off a chain reaction of internal chaos. Binding the drug to its target stops growth, but a second, bacteria-driven process is needed to actually trigger the suicidal enzymes that dissolve the wall during autolysis.4PubMed Central. Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin The distinction matters: bacteria that lack certain autolysins, or that somehow suppress the death-signal pathway, can be inhibited by penicillin without being killed outright, which is one reason some infections are harder to clear than others.
What Happens at Doses Too Low to Kill
When bacteria encounter penicillin at concentrations below the level needed to kill them, the effects on cell shape and division can be dramatic without being immediately lethal. Researchers studying Neisseria meningitidis exposed to sub-killing concentrations of penicillin observed a range of abnormal cell forms. Many cells could not form proper division walls or orient their division machinery correctly. Some overproduced wall material at division sites, creating bulges and malformed shapes instead of the neat splitting that normally turns one cell into two.5PubMed Central. Anomalous cellular morphology and growth characteristics of Neisseria meningitidis in subminimal inhibitory concentrations of penicillin G
These misshapen cells are not just laboratory curiosities. In a clinical setting, sub-lethal antibiotic exposure is common: drug concentrations fluctuate as doses are absorbed and metabolized, and bacteria in deep-tissue infections or biofilms may never see the full concentration that reaches the bloodstream. Cells exposed to these intermediate levels can survive in distorted forms, potentially continuing to cause problems even as antibiotic therapy appears to be working. The morphological chaos also hints at how important the cell wall is not just for structural support but for coordinating the entire process of cell division.
The Gram-Negative Barrier
Not all bacteria present the same target to penicillin. Gram-positive bacteria, like staphylococci and streptococci, have a thick peptidoglycan layer exposed on their outer surface, making it relatively accessible. Gram-negative bacteria, like E. coli and Pseudomonas, have a thinner peptidoglycan layer sandwiched between an inner membrane and an additional outer membrane. That outer membrane acts as a physical barrier that many antibiotics, including certain penicillins, struggle to cross.
Hydrophilic antibiotics, including most penicillins, generally have to pass through protein channels called porins embedded in the outer membrane to reach the peptidoglycan layer underneath.6PubMed Central. Outer membrane permeability and antibiotic resistance The size and charge of these porins determine which drugs get through and how quickly. This is why some penicillins are effective against gram-positive organisms but weak against gram-negative ones, and why chemists have spent decades modifying penicillin’s side chains to improve its ability to slip through porins. Ampicillin and amoxicillin, for instance, were specifically engineered with chemical modifications that improve gram-negative penetration compared to the original penicillin G.
Bacteria can exploit this bottleneck as a resistance strategy. By mutating their porins to reduce their diameter or by reducing the number of porins they produce, gram-negative bacteria can starve incoming penicillin of its entry route. Some species go a step further and deploy efflux pumps, molecular machines that actively eject antibiotics back out of the cell before they reach the PBPs.7PubMed Central. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance These influx and efflux modifications are considered a major contributor to the global rise of antibiotic resistance.
L-Forms and Bacteria That Ditch Their Walls
One of the more surprising outcomes of penicillin exposure is that some bacteria do not simply die when their walls are destroyed. Instead, they shed the wall entirely and transition into a cell-wall-free state known as an L-form. These cells look completely different from their walled parents: instead of rods or spheres held in shape by rigid peptidoglycan, they become large, blobby, irregularly shaped cells that proliferate by a primitive budding and splitting mechanism rather than by conventional division.
L-form survival depends on ramping up membrane production. Without a rigid wall to define their shape, these cells need excess membrane to drive the shape deformations that allow one cell to pinch off into two. Research has shown that this can happen when the shutdown of peptidoglycan production indirectly triggers increased fatty acid synthesis for membranes, creating an imbalance between surface area and volume that drives scission, a kind of mechanical splitting.8PubMed Central. L-form bacteria, chronic diseases and the origins of life The process has been demonstrated in diverse bacterial species. Inhibiting the peptidoglycan assembly pathway with different drugs, not just penicillin, can trigger L-form transitions in organisms as varied as Bacillus subtilis, E. coli, and Corynebacterium glutamicum, with all three producing strikingly similar large spheroidal cells.9eLife. General principles for the formation and proliferation of a wall-free (L-form) state in bacteria
The clinical significance of L-forms is an active area of debate, but the concern is real: these wall-free cells are invisible to penicillin, since the drug’s target no longer exists on them. They can persist inside host tissues in a dormant-like state and, once the antibiotic pressure is removed, revert to their normal walled form.10PubMed Central. Bacterial L-forms: Key Mechanisms of Drug Resistance, Disease Recurrence, and Immune Evasion This reversion could explain some cases of relapsing infection after apparently successful antibiotic treatment. L-forms also evade parts of the immune system that rely on recognizing cell wall components, making them harder for the body to clear on its own.
How Bacteria Resist Penicillin
The most widespread resistance mechanism against penicillin is enzymatic destruction. Bacteria produce enzymes called beta-lactamases that break apart penicillin’s core ring structure, the very feature that allows the drug to mimic the cell wall building block. Once the ring is cleaved, the drug can no longer bind to PBPs. Over 2,000 distinct beta-lactamase enzymes have been identified in nature, ranging from narrow-spectrum versions that only break down a few penicillins to broad-spectrum variants capable of destroying nearly every beta-lactam antibiotic available.11PubMed Central. β-Lactamases: A Focus on Current Challenges
A different strategy is used by methicillin-resistant Staphylococcus aureus, better known as MRSA. Rather than destroying the drug, MRSA acquires a gene called mecA that encodes an alternative penicillin-binding protein, PBP2a. This substitute enzyme can carry out the cross-linking work of building the cell wall, but its active site has such a low affinity for beta-lactam antibiotics that penicillin essentially slides off it without forming a stable bond.12PubMed Central. Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review PBP2a takes over the jobs of the bacterium’s normal PBPs, keeping the wall intact even when penicillin saturates the cell. This makes MRSA resistant not just to methicillin but to virtually all standard beta-lactam antibiotics.13PubMed Central. Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus
These are not the only tricks. As discussed with gram-negative bacteria, changes to porins and efflux pumps form a third line of defense that works alongside or independently of beta-lactamases. Many resistant bacteria combine several mechanisms at once: producing a beta-lactamase to degrade the drug, reducing porin expression to limit how much drug enters, and running efflux pumps to expel whatever gets through. This layered defense is what makes multi-drug-resistant infections so difficult to treat.
Pairing Penicillin with Beta-Lactamase Inhibitors
One of the most successful strategies for overcoming beta-lactamase resistance has been to pair penicillin-type drugs with molecules that disable the destructive enzymes. Clavulanic acid, the most familiar of these, is combined with amoxicillin in the widely prescribed medication Augmentin. Clavulanic acid has a beta-lactam ring of its own but is a poor antibiotic on its own. Instead, it acts as a sacrificial target: it binds to the beta-lactamase and forms a stable complex that ties up the enzyme, leaving the actual antibiotic free to reach PBPs and do its job.
How clavulanic acid inhibits these enzymes at a molecular level has been debated for years. Recent work has clarified that the primary mechanism involves formation of a stable complex with the enzyme without necessarily requiring the clavulanic acid molecule to break apart into fragments, as was previously assumed from older laboratory studies conducted under acidic conditions that do not reflect what happens inside the body.14PubMed. How Clavulanic Acid Inhibits Serine β-Lactamases This matters because understanding exactly how the inhibitor works guides the design of next-generation inhibitors, some of which are already in clinical use against bacteria that have evolved resistance even to clavulanic acid itself.
Cell Wall Debris and the Immune System
When penicillin causes a bacterial cell to rupture, the fragments of the cell wall do not just disappear. Pieces of peptidoglycan scatter into the surrounding tissue, and the human immune system has evolved specific sensors to detect them. Two key intracellular receptors, known as Nod1 and Nod2, recognize distinct fragments of the peptidoglycan structure. Nod2 detects a sugar-amino acid fragment common to most bacteria, while Nod1 is tuned to a slightly different fragment found mainly in gram-negative species.15PubMed. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2
This means that penicillin-induced lysis does not just remove the bacterium; it also broadcasts an alarm signal to the immune system by releasing the very molecular patterns that immune sensors are built to detect. In many infections, this is beneficial: the burst of cell wall fragments amplifies the immune response and helps clear remaining bacteria. But it can also have a downside. In severe infections like bacterial meningitis, the sudden release of large quantities of cell wall debris from mass bacterial lysis can provoke intense inflammation that damages host tissues. This is one reason why clinicians sometimes give anti-inflammatory drugs alongside antibiotics in certain infections, to dampen the immune overreaction to the flood of bacterial fragments.
The specificity of Nod1 and Nod2 also means that how bacteria process and modify their own peptidoglycan, trimming it, altering its sugar components, or coating it with additional molecules, can change how visible they are to the immune system. Some pathogens have evolved modifications to their cell wall chemistry that reduce the generation of fragments detectable by Nod receptors, essentially making their walls harder for the immune system to “see” even when those walls are disrupted.
Bacterial Stress Responses to Wall Damage
Bacteria do not passively accept the damage penicillin inflicts. They have evolved sophisticated sensory systems that detect wall stress and trigger defensive responses. In gram-negative species like E. coli, signaling pathways known as the Rcs and Cpx systems act as sentinels for the cell envelope. These systems use sensor proteins positioned in or near the outer membrane and cell wall to monitor the integrity of the envelope. When wall damage is detected, these pathways activate genes that help the bacterium cope: thickening remaining wall material, modifying outer membrane composition, or upregulating repair enzymes.
The Rcs system is particularly interesting because it uses a protein called RcsF that is normally threaded through outer membrane proteins. When the wall or outer membrane is stressed, RcsF cannot be properly assembled into its usual position, and the resulting “orphaned” sensor protein triggers the alarm cascade. This means the bacterium is essentially monitoring the quality of its own construction process in real time, and penicillin’s disruption of that process sets off alarms that can sometimes help the cell survive sub-lethal exposures. These stress responses can contribute to tolerance, a state where bacteria are not genetically resistant to the antibiotic but can survive temporary exposure by slowing growth or activating protective pathways.
Resistance Genes That Predate Human Medicine
One common misconception is that antibiotic resistance is purely a modern phenomenon created by the overuse of antibiotics since the mid-twentieth century. In reality, beta-lactamase genes and other resistance mechanisms existed long before humans began manufacturing penicillin. Soil bacteria and fungi have been waging chemical warfare against one another for hundreds of millions of years, and the genes encoding beta-lactamases evolved as part of that ancient arms race.
A study of pristine Antarctic soils, far from any human antibiotic use, found that genes conferring resistance to beta-lactam antibiotics were common even in these remote environments.16PubMed Central. A reservoir of ‘historical’ antibiotic resistance genes in remote pristine Antarctic soils What human antibiotic use has done is not create resistance from scratch but drastically accelerate its spread. When penicillin floods an environment, whether a patient’s body or a hospital wastewater stream, bacteria carrying pre-existing resistance genes survive while susceptible ones die. The survivors proliferate and share those genes with other species through horizontal gene transfer, a process by which bacteria swap genetic material directly without having to reproduce. The ancient origins of resistance underscore why managing antibiotic use is so important: the raw genetic material for resistance is already everywhere, and heavy antibiotic pressure simply selects for it at an accelerated pace.